Sevabertinib Patent Expiration

Sevabertinib was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Hyrnuo on Nov 19, 2025.


Sevabertinib Patents

Given below is the list of patents protecting Sevabertinib, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Hyrnuo US10428063 Jan 25, 2036 Bayer Healthcare



Sevabertinib's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sevabertinib Generic API Manufacturers

Given below is the list of companies who have filed for Sevabertinib generic, along with the locations of their manufacturing plants worldwide.